Ubs Oconnor LLC En V Veno Medical Corp Transaction History
Ubs Oconnor LLC
- $1.59 Billion
- Q1 2024
A detailed history of Ubs Oconnor LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 226,308 shares of NVNO stock, worth $1.15 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
226,308Holding current value
$1.15 Million% of portfolio
0.08%Shares
9 transactions
Others Institutions Holding NVNO
# of Institutions
37Shares Held
4.05MCall Options Held
274KPut Options Held
17.8K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$3.32 Million0.43% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$3.16 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$2.91 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT496KShares$2.51 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$2.03 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $48M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...